Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Molecular Cancer Therapeutics
|
December 10, 2009
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Joan M Carboni, Mark Wittman, Zheng Yang, et al.
Journal of Medicinal Chemistry
|
September 4, 2008
Discovery and evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an orally efficacious inhibitor of insulin-like growth factor-1 receptor kinase with broad spectrum in vivo antitumor activity
Upender Velaparthi, Mark Wittman, Peiying Liu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 20, 2025
The Association between Proteomic Aging Clocks and the Risk of Cancer in Midlife Individuals
Shuo Wang, Zexi Rao, Aixin Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 18, 2024
Rapid Initiation of Antiretroviral Therapy With Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Versus Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate in HIV-Positive Men Who Have Sex With Men in China: Week 48 Results of the Multicenter, Randomized Clinical Trial
Ran Wang, Lijun Sun, Xi Wang, et al.
International Journal of Antimicrobial Agents
|
November 29, 2024
HIV-1 viral decay in blood and semen in antiretroviral-naïve adults initiating dolutegravir/lamivudine vs. bictegravir/emtricitabine/tenofovir alafenamide
Yongjian Liu, Ran Wang, Lijun Sun, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 16, 2010
SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors
Kurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Cancer Research
|
May 4, 2005
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor
Joan M Carboni, Adrian V Lee, Darryl L Hadsell, et al.
Circulation
|
February 16, 2026
Novel Plasma Proteomic Markers and Risk of Venous Thromboembolism
Weihong Tang, Aixin Li, Thomas R Austin, et al.
Journal of Medicinal Chemistry
|
September 2, 2005
Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity
Mark Wittman, Joan Carboni, Ricardo Attar, et al.
Emerging Microbes & Infections
|
October 16, 2025
Enhanced replication of a contemporary avian influenza A H9N2 virus in human respiratory organoids
Lin-Lei Chen, Jonathan Daniel Ip, Wan-Mui Chan, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Molecular Cancer Therapeutics
|
December 10, 2009
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Joan M Carboni, Mark Wittman, Zheng Yang, et al.
Journal of Medicinal Chemistry
|
September 4, 2008
Discovery and evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an orally efficacious inhibitor of insulin-like growth factor-1 receptor kinase with broad spectrum in vivo antitumor activity
Upender Velaparthi, Mark Wittman, Peiying Liu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 20, 2025
The Association between Proteomic Aging Clocks and the Risk of Cancer in Midlife Individuals
Shuo Wang, Zexi Rao, Aixin Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 18, 2024
Rapid Initiation of Antiretroviral Therapy With Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Versus Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate in HIV-Positive Men Who Have Sex With Men in China: Week 48 Results of the Multicenter, Randomized Clinical Trial
Ran Wang, Lijun Sun, Xi Wang, et al.
International Journal of Antimicrobial Agents
|
November 29, 2024
HIV-1 viral decay in blood and semen in antiretroviral-naïve adults initiating dolutegravir/lamivudine vs. bictegravir/emtricitabine/tenofovir alafenamide
Yongjian Liu, Ran Wang, Lijun Sun, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 16, 2010
SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors
Kurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Cancer Research
|
May 4, 2005
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor
Joan M Carboni, Adrian V Lee, Darryl L Hadsell, et al.
Circulation
|
February 16, 2026
Novel Plasma Proteomic Markers and Risk of Venous Thromboembolism
Weihong Tang, Aixin Li, Thomas R Austin, et al.
Journal of Medicinal Chemistry
|
September 2, 2005
Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity
Mark Wittman, Joan Carboni, Ricardo Attar, et al.
Emerging Microbes & Infections
|
October 16, 2025
Enhanced replication of a contemporary avian influenza A H9N2 virus in human respiratory organoids
Lin-Lei Chen, Jonathan Daniel Ip, Wan-Mui Chan, et al.
Page
of 10